Home LiteratureArticle Details
PMID: 909215 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis.

The Johns Hopkins medical journal ·Vol. 141 ·No. 4 ·1977-10-00 ·Pages 193-7

Arnett FC, Hochberg MC, Bias WB

Abstract

Proposed mechanisms to explain the association of HLA-B27 with Reiter's syndrome (RS) and ankylosing spondylitis (AS) include abnormal immune response genes linked to HLA or a direct role for HLA antigens in disease pathogenesis. Our studies provide indirect evidence to support the latter hypothesis. Seventy-nine patients (44 with RS, 27 with AS and 8 with idiopathic sacroiliitis [SI]) were evaluated clinically and by HLA phenotyping. Of the 10 patients with RS who were B27-negative, 7 (70%) had another B locus antigen that was immunologically cross-reactive with B27 (B7-group antigen). These included B7 in two, BW22 in four, and BW42 in one. Four of eight patients with sacroiliitis alone had B27, but the remaining four all had B7. Two B27-negative AS patients had no B7-group antigens. Thus, 69% of B27-negative patients had cross-reactive HLA antigens.

MeSH Terms
Adolescent Adult Arthritis, Reactive/immunology Cross Reactions Female HLA Antigens/analysis Humans Male Middle Aged Phenotype Sacroiliac Joint Spondylitis, Ankylosing/immunology
Chemicals
HLA Antigens
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Arnett F C
Hochberg M C
Bias W B
Article Info
Journal
The Johns Hopkins medical journal
Abbr.
Johns Hopkins Med J
ISSN
0021-7263
Published
1977-10-00
Pages
193-7
Language
English
Region
United States
NLM ID
0072456
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]